Mdm2 binds p73α without targeting degradation

Oncogene

Volumn 18, Issue 27, 1999, Pages 3923-3929

  Bálint, Eva ^a   Bates, Stewart ^a   Vousden, Karen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

E6; Mdm2; p53; p73; Protein degradation

Indexed keywords

PROTEASOME; PROTEIN MDM2; PROTEIN P53; PROTEIN P73ALPHA; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION; WART VIRUS;

AMINO ACID SEQUENCE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; OSTEOSARCOMA; PAPILLOMAVIRIDAE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033536230     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202781     Document Type: Article

References (29)

1. Bates S, Ryan KM, Phillips AC and Vousden KH. (1998). Oncogene, 17, 1691-1703.
2. Böttger A, Böttger V, Sparks A, Lium W-L, Howard SF and Lane DP. (1997). Curr. Biol., 7, 860-869.
3. Chen J, Lin J and Levine AJ. (1995). Mol. Med., 1, 142-152.
4. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vousden KH. (1992). Lancet, 339, 1070-1073.
5. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni M, Falco M, Annicchiarico-Petruzzelli M, Levrero M and Melino G. (1998). J. Exp. Med., 188, 1763-1768.
6. Foster SA, Demers GW, Etscheid BG and Galloway DA. (1994). J. Virol., 68, 5698-5705.
7. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
8. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R and Harris CC. (1994). Nuc. Acids Res., 22, 3551-3555.
9. Jost CA, Marin MC and Kaelin Jr, WG. (1997). Nature, 389, 191-194.
10. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
11. Kubbutat MHG, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
12. Kubbutat MHG, Ludwig RL, Ashcroft M and Vousden KH. (1998). Mol. Cell. Biol., 18, 5690-5698.
13. Kubbutat MHG, Ludwig RL, Levine AJ and Vousden KH. (1999). Cell Growth and Diff., In press.
14. Kubbutat MHG and Vousden KH. (1998). Mol. Med. Today, 4, 250-256.
15. Kussie PH, Gorina S, Marechal V, Elenbaas R, Moreau J, Levine AJ and Pavletich NP. (1996). Science, 274, 948-953.
16. Levine AJ. (1997). Cell, 88, 323-331.
17. Ludwig RL, Bates S and Vousden KH. (1996). Mol. Cell. Biol., 16, 4952-4960.
18. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D and Kaelin Jr, WG. (1998). Mol. Cell. Biol., 18, 6316-6324.
19. Marston NJ, Crook T and Vousden KH. (1994). Oncogene, 9, 2707-2716.
20. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
21. Momand J, Zambetti GP, George DL and Levine AJ. (1992). Cell, 69, 1237-1245.
22. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
23. Pavletich NP. (1996). Science, 274, 948-953.
24. Picksley SM, Vojtesek B, Sparks A and Lane DP. (1994). Oncogene, 9, 2523-2529.
25. Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M and El-Deiry WS. (1998). Int. J. Oncol., 13, 5-9.
26. Roth J, König C, Wienzek S, Weigel S, Ristea S and Dobbelstein M. (1998). J. Virol., 72, 8510-8516.
27. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
28. Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RCA, van der Houven van Oordt W, Hateborer G, van der Ed AJ and Jochemsen AG. (1996). EMBO J., 15, 5349-5357.
29. Zhu J, Jiang J, Zhou W and Chen X. (1998). Cancer Res., 58, 5061-5065.